APA (7th ed.) Citation

Wan, K., Yu, L., Feng, S., Xie, Z., Li, Y., Jing, X., . . . Li, W. (2025). A novel bispecific affitoxin simultaneously targeting E7 of HPV16/18 types: Superior anti-tumor activity and EMT reversal in HPV-driven cervical cancer therapy. Journal of Translational Medicine, 23(1), 1. https://doi.org/10.1186/s12967-025-06971-9

Chicago Style (17th ed.) Citation

Wan, Kairong, Lijun Yu, Sicong Feng, Zhenyun Xie, Yanheng Li, Xisha Jing, Junze Wu, Lifang Zhang, and Wenshu Li. "A Novel Bispecific Affitoxin Simultaneously Targeting E7 of HPV16/18 Types: Superior Anti-tumor Activity and EMT Reversal in HPV-driven Cervical Cancer Therapy." Journal of Translational Medicine 23, no. 1 (2025): 1. https://doi.org/10.1186/s12967-025-06971-9.

MLA (9th ed.) Citation

Wan, Kairong, et al. "A Novel Bispecific Affitoxin Simultaneously Targeting E7 of HPV16/18 Types: Superior Anti-tumor Activity and EMT Reversal in HPV-driven Cervical Cancer Therapy." Journal of Translational Medicine, vol. 23, no. 1, 2025, p. 1, https://doi.org/10.1186/s12967-025-06971-9.